Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/09/2002EP1246637A2 Methods of modulation of the immune system
10/09/2002EP1246631A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373672A Blocking immune response to foreign antigen using antagonist which binds to CD20
10/09/2002CN1373668A Hybrid peptide modulate immune response
10/09/2002CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances
10/09/2002CN1373663A Use of 2-imidazolyl substd, carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372955A Oral liquid 'Gubao' and its preparing process
10/09/2002CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/09/2002CN1092053C Process for preparing active aloe powder
10/09/2002CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/08/2002US6462086 Non-malignant disease treatment with Ras antagonists
10/08/2002US6462078 Antiinflammatory agents; library of plant extracts
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462072 Such as 4,4-diphenylcyclohexl-1-(3,3-dimethyl-2-oxopentan-oyl)-pyrrolidine-2 -carboxylate; rotamase inhibitors; neuronal repair and regrowth; parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002US6461615 Therapeutic and prophylactic methods using heat shock proteins
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077237A2 Transporters and ion channels
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076506A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076497A2 Method and composition
10/03/2002WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
10/03/2002WO2002076493A1 Novel drugs for preventing/treating immunopathic diseases
10/03/2002WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002WO2002076483A2 Bacteriophage preparation
10/03/2002WO2002076471A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076401A2 Method of attenuating reactions to skin irritants
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002058728A3 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002022657A3 Peptide antagonist of multiple chemokine receptors and uses thereof
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2002009744A3 Modified sialic acid vaccines
10/03/2002WO2002002751A3 Alteration of cell membrane
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020143149 Seven trans-membrane receptor-Fitz2
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143057 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142945 Immunomodulatory methods using carbohydrate antigens
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1172